Kinea Bio

Seattle, United States

Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments.

$1.1M raised

Sep 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Kinea Bio raised?

Kinea Bio has raised $1.1M in total funding. The most recent round was Grant. The last funding was announced in September 2025.

Who are Kinea Bio's investors?

Kinea Bio's investors include Jain Foundation, Parent Project Muscular Dystrophy.

Where is Kinea Bio headquartered?

Kinea Bio is headquartered in Seattle, United States.

What does Kinea Bio do?

Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments.

What stage is Kinea Bio at?

Kinea Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 23, 2025.

MLA

"Kinea Bio — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/kinea-bio. Accessed July 3, 2026.

APA

VCBacked. (2025). Kinea Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/kinea-bio

Wikipedia (cite web)

{{cite web |title=Kinea Bio — Funding & Investors |url=https://www.vcbacked.co/company/kinea-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 23, 2025.